Determine Your Priorities to Finding the Right CDMO

This article is the second part of our “Best Practices in the CDMO Selection Process” series, in which we explore how to internally prepare your selection criteria for finding a Contract Development and Manufacturing Organization (CDMO).

Blog
Published on:
September 1, 2022

In this article, we will detail the best practices for working with a CDMO to ensure the success of your product development. After having identified the need for engaging a CDMO, the next steps would entail the evaluation of your options. Before looking at a CDMO’s capabilities, it’s important to assess your priorities as the sponsor company.

CDMOs also vary in technological competencies and abilities and it’s important to understand the strengths and limitations of each CDMO in order to select the ones most suitable to match your priorities.
Creating a Target Product Profile or TPP

The foundation for CDMO selection begins with creating a Target Product Profile (TPP). This is an in-depth roadmap of your product—what qualities define it, how it will be administered and what clinical setting it will be used in. The TPP should include:

  • Product description
  • Indications and usage
  • Dosage and administration
  • Dosage forms and strengths
  • Manufacturing technology and process
  • Scale of production
  • Storage condition

The TPP is a living document that evolves alongside the overall product development plan and serves as your company’s guideline throughout the process. It aids in matching priorities to the extent that they are known. We recommend a review of the FDA’s guidance document from March 2007 on writing a TPP for best practices.

Understanding and outlining your Priorities

Before selecting a CDMO for your project or company, you need to define three major factors:

  • Quality
  • Timeline
  • Cost

Quality is of top priority when it comes to manufacturing pharmaceuticals and cannot be compromised at all. Generally, timeline and cost vary inversely, so a decision needs to be made as to your second highest priority. If the timeline is of greater importance, expect to pay more for the requested services. If cash flow is limited and cost is of second priority, you may need to be flexible on the timeline.

Keep in mind that as a sponsor, you may believe that you have a failsafe product; however, when scaled, it may prove otherwise. This can lead to both increased time and cost. CDMOs also vary in technological competencies and abilities and it’s important to understand the strengths and limitations of each CDMO in order to select the ones most suitable to match your priorities.

Once a TPP is in place, begin your evaluation process by developing a list of candidate CDMOs. Create your own list or enlist the assistance of a consulting group with solid expertise to assist in finding suitable candidates.

Creating a like-for-like comparison

Next, draft your Request for Proposal (RFP) using the information contained in your TPP, defining the requested scope of work and associated timeline. A single RFP is needed to describe your project and that RFP can be issued to multiple CDMOs previously identified as suitable candidates for your project. Our recommendation is to send the RFP to 6–8 CDMOs, as not all CDMOs will respond.

CDMOs have business development teams in place, who receive RFPs and draft proposals in response. Allow 3–4 weeks for receipt of proposals, which will be returned to you by the due date specified in your RFP. Since all CDMOs are responding to the same RFP, you can pull similar information from each response proposal into a single spreadsheet to generate a straightforward, like-for-like comparison.

Using this comparison spreadsheet, rank your candidate CDMOs using weighted criteria reflecting your top priorities while also considering risk to quality, timeline and cost. This comparison and knowing what to look for in the right CDMO will help you make the right selection.

If you have decided to outsource your manufacturing and would like to identify the right CDMO for your project, we are here to assist. Our expert team has been helping companies choose the right CDMO for more than a decade — reach out to us to learn how we can support.

Related news

Blog May 24, 2023
Planning: Why It’s Worth the Time for Biotech Companies
Biotech expert Joris Pezzini covers the fundamentals of planning, one of the three required jobs for biotech leaders to be successful.
Biotech
News May 22, 2023
Alira Health Joins France Biotech as an Expert Partner
We are pleased to announce that Alira Health has joined France Biotech, an independent association that brings together healthcare innovation entrepreneurs and their expert partners.
Biotech Clinical Trials France Patient Engagement
Events May 15, 2023
BIO International Convention
We are excited to share that we will be attending the BIO International Convention in Boston. This leading industry event attracts biotechnology and pharma leaders for one week of intensive(...)
Biotech Pharma
Blog April 27, 2023
The Biotech Industry Today: What Leaders Need to Know
Biotech companies today face a complex and often difficult funding, regulatory, and market access environment.
Biotech
Multimedia March 24, 2023
Webinar Replay: MedTech CDMO: Market and M&A Trends in the U.S. in 2023
Watch this webinar hosted by MassMEDIC to discover the current trends shaping the US medical device outsourcing landscape, with a particular focus on its performance and business outlook,(...)
CDMO MedTech
Events March 6, 2023
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
Biotech Market Access Pharma Real-World Evidence (RWE)
Blog March 6, 2023
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Biotech Market Access MedTech Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.